Those of us working in global health know better than most how interconnected today’s world is. This was shown in stark terms during the COVID-19 pandemic, and we are reminded of this daily as the ripples from conflict, humanitarian crises, and climate change are felt everywhere.
The war in Iran is no different. This week, the price of Brent crude rose to over $100 a barrel, triggering a supply shortage and a surge in energy prices. Despite efforts to stabilize prices, reports state that the oil price is nearly a quarter higher than when the war began.
What might be less obvious is how the impact of these surging costs will be felt by those working in biomedical research and development.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Céline Aerts
Céline Aerts is a health economist and global health R&D policy specialist with a Ph.D. and over a decade of experience in economic evaluation and evidence-informed policy analysis. She is a senior analyst at Impact Global Health, where she co-leads the health and economic impact portfolio, producing analyses that quantify the health, societal, and economic returns of R&D investments and products.
Search for articles
Most Read
- 1
- 2
- 3
- 4
- 5